These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 27235004)

  • 1. Periprocedural Anticoagulation Management of Patients with Thrombophilia.
    Wysokinska EM; Wysokinski WE; Ketha S; Litin S; Daniels P; Slusser J; Hodge DO; Heit JA; McBane RD
    Am J Med; 2016 Sep; 129(9):986-92. PubMed ID: 27235004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Periprocedural anticoagulation management of patients with nonvalvular atrial fibrillation.
    Wysokinski WE; McBane RD; Daniels PR; Litin SC; Hodge DO; Dowling NF; Heit JA
    Mayo Clin Proc; 2008 Jun; 83(6):639-45. PubMed ID: 18533080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Periprocedural anticoagulation management of patients with venous thromboembolism.
    McBane RD; Wysokinski WE; Daniels PR; Litin SC; Slusser J; Hodge DO; Dowling NF; Heit JA
    Arterioscler Thromb Vasc Biol; 2010 Mar; 30(3):442-8. PubMed ID: 20139361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of major bleeding in peri-procedural anticoagulation management.
    Tafur AJ; McBane R; Wysokinski WE; Litin S; Daniels P; Slusser J; Hodge D; Beckman MG; Heit JA
    J Thromb Haemost; 2012 Feb; 10(2):261-7. PubMed ID: 22123000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three-month cumulative incidence of thromboembolism and bleeding after periprocedural anticoagulation management of arterial vascular bypass patients.
    Attaya H; Wysokinski WE; Bower T; Litin S; Daniels PR; Slusser J; Heit JA; McBane RD
    J Thromb Thrombolysis; 2013 Jan; 35(1):100-6. PubMed ID: 22843195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombophilia: Testing rarely useful after a venous thromboembolic event.
    Prescrire Int; 2017 May; 26(182):129. PubMed ID: 30730674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of thromboembolism with short-term interruption of warfarin therapy.
    Garcia DA; Regan S; Henault LE; Upadhyay A; Baker J; Othman M; Hylek EM
    Arch Intern Med; 2008 Jan; 168(1):63-9. PubMed ID: 18195197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen.
    Douketis JD; Johnson JA; Turpie AG
    Arch Intern Med; 2004 Jun; 164(12):1319-26. PubMed ID: 15226166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-molecular-weight-heparins as periprocedural anticoagulation for patients on long-term warfarin therapy: a standardized bridging therapy protocol.
    Jaffer AK; Ahmed M; Brotman DJ; Bragg L; Seshadri N; Qadeer MA; Klein A
    J Thromb Thrombolysis; 2005 Aug; 20(1):11-6. PubMed ID: 16133889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of thrombophilia screening on venous thromboembolism management practices.
    Garcia-Horton A; Kovacs MJ; Abdulrehman J; Taylor JE; Sharma S; Lazo-Langner A
    Thromb Res; 2017 Jan; 149():76-80. PubMed ID: 27931012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer effect on periprocedural thromboembolism and bleeding in anticoagulated patients.
    Tafur AJ; Wysokinski WE; McBane RD; Wolny E; Sutkowska E; Litin SC; Daniels PR; Slusser JP; Hodge DO; Heit JA
    Ann Oncol; 2012 Aug; 23(8):1998-2005. PubMed ID: 22473596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peri-procedural anticoagulation management of mechanical prosthetic heart valve patients.
    Daniels PR; McBane RD; Litin SC; Ward SA; Hodge DO; Dowling NF; Heit JA
    Thromb Res; 2009 Jul; 124(3):300-5. PubMed ID: 19232682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombophilic abnormalities and recurrence of venous thromboembolism in patients treated with standardized anticoagulant treatment.
    Santamaria MG; Agnelli G; Taliani MR; Prandoni P; Moia M; Bazzan M; Guazzaloca G; Ageno W; Bertoldi A; Silingardi M; Tomasi C; Ambrosio GB;
    Thromb Res; 2005; 116(4):301-6. PubMed ID: 16038714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of dabigatran versus warfarin in patients with acute venous thromboembolism in the presence of thrombophilia: Findings from RE-COVER®, RE-COVER™ II, and RE-MEDY™.
    Goldhaber SZ; Eriksson H; Kakkar A; Schellong S; Feuring M; Fraessdorf M; Kreuzer J; Schueler E; Schulman S
    Vasc Med; 2016 Dec; 21(6):506-514. PubMed ID: 27807306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variations in perioperative warfarin management: outcomes and practice patterns at nine hospitals.
    Jaffer AK; Brotman DJ; Bash LD; Mahmood SK; Lott B; White RH
    Am J Med; 2010 Feb; 123(2):141-50. PubMed ID: 20103023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Idiopathic venous thromboembolism and thrombophilia.
    Sinescu C; Hostiuc M; Bartos D
    J Med Life; 2011; 4(1):57-62. PubMed ID: 21505575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Periprocedural stroke and bleeding complications in patients undergoing catheter ablation of atrial fibrillation with different anticoagulation management: results from the Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter Ablation (COMPARE) randomized trial.
    Di Biase L; Burkhardt JD; Santangeli P; Mohanty P; Sanchez JE; Horton R; Gallinghouse GJ; Themistoclakis S; Rossillo A; Lakkireddy D; Reddy M; Hao S; Hongo R; Beheiry S; Zagrodzky J; Rong B; Mohanty S; Elayi CS; Forleo G; Pelargonio G; Narducci ML; Dello Russo A; Casella M; Fassini G; Tondo C; Schweikert RA; Natale A
    Circulation; 2014 Jun; 129(25):2638-44. PubMed ID: 24744272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of venous thromboembolism and hemorrhage related safety studies of preoperative anticoagulation therapy in hip fracture patients undergoing surgical treatment: a case-control study.
    Liu Z; Han N; Xu H; Fu Z; Zhang D; Wang T; Jiang B
    BMC Musculoskelet Disord; 2016 Feb; 17():76. PubMed ID: 26873584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A feasibility study of continuing dose-reduced warfarin for invasive procedures in patients with high thromboembolic risk.
    Larson BJ; Zumberg MS; Kitchens CS
    Chest; 2005 Mar; 127(3):922-7. PubMed ID: 15764777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapy Insight: management of urology patients taking long-term warfarin anticoagulation therapy.
    Daniels PR
    Nat Clin Pract Urol; 2005 Jul; 2(7):343-50. PubMed ID: 16474787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.